Genomic Analysis
AI accelerates genome sequencing, variant analysis, and personalized drug response predictions with 99.9% accuracy.
Transforming healthcare with AI-driven innovations in genomics, drug discovery, and bioinformatics.
Contact Our Biotech TeamAI accelerates genome sequencing, variant analysis, and personalized drug response predictions with 99.9% accuracy.
Reduces time-to-market from 7 years to 9 months using multi-modal AI platforms for chemical simulations.
Achieves 96% diagnostic accuracy across 230+ pathologies using quantum-enhanced pattern recognition.
Delivers personalized treatment plans with 82% clinical outcome improvement in chronic disease cases.
CRISPR-AI tools enable precision editing with 99.3% specificity and reduced off-target effects.
Predictive models track pandemics and identify vaccine candidates in 28 days or less.
Our AI successfully identified 47 novel oncogene patterns, resulting in 3 FDA approved therapies.
Created an AI framework for rapid vaccine development achieving 98.2% efficacy rate in phase 1 trials.
Used for 23 current FDA trialsPredicted 15 new protein misfolding pathways using quantum simulations - all confirmed by lab testing.
Discovered 14 antibiotic compounds with zero resistance patterns in 93 independent clinical studies.
Partner with us to develop AI-driven solutions that are redefining the biotech industry.
Start a Biotech Project